HUTCHMED (China) (HCM) Non-Current Debt (2015 - 2025)
HUTCHMED (China)'s (HCM) quarterly Non-Current Debt came in at $68.2 million in Q4 2025, up 0.51% on a QoQ basis from $67.8 million in Q2 2025.
HUTCHMED (China) (HCM) Non-Current Debt (2015 - 2025) Analysis & Trends
HUTCHMED (China) (HCM) has 11 years of Non-Current Debt data on file, last reported at $68.2 million in Q4 2025.
- On a quarterly basis, Non-Current Debt changed N/A year-over-year to $68.2 million in Q4 2025; TTM through Dec 2025 was $68.2 million, a N/A change from a year earlier, with the FY2025 full-year figure at $68.2 million, changed N/A from the prior year.
- Non-Current Debt for Q4 2025 stood at $68.2 million, up from $67.8 million in the prior quarter.
- Over the last five years, Non-Current Debt for HCM reached as high as $68.2 million in Q4 2025 and fell as low as $18.1 million in Q4 2022.
- Historically, Non-Current Debt has averaged $46.1 million across 5 years, with a median of $47.9 million in 2023.
- Across the five-year window, Non-Current Debt jumped 38.57% in 2024 and advanced 21.95% in 2025, its largest moves.
- Year by year, Non-Current Debt stood at $26.9 million in 2021, then slumped by 32.63% to $18.1 million in 2022, then jumped by 121.76% to $40.1 million in 2023, then soared by 38.57% to $55.6 million in 2024, then grew by 22.57% to $68.2 million in 2025.
- Per Business Quant data, the three most recent Non-Current Debt figures were $68.2 million in Q4 2025, $67.8 million in Q2 2025, and $55.6 million in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 10.34 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 14.02 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 27.86 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 12.41 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.74 Bn |
| 10 | HUTCHMED (China) | 241.90 Mn | 243.61 Mn | - | 68.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 68.19 Mn |
| Jun 30, 2025 | 67.84 Mn |
| Jun 30, 2024 | 55.63 Mn |
| Jun 30, 2023 | 40.15 Mn |
| Dec 31, 2022 | 18.10 Mn |
| Mar 31, 2021 | 26.87 Mn |
| Jun 30, 2020 | 26.84 Mn |
| Mar 31, 2019 | 26.76 Mn |
| Dec 31, 2018 | 26.74 Mn |
| Jun 30, 2018 | 26.69 Mn |
| Jun 30, 2017 | 19.99 Mn |
| Dec 31, 2016 | 26.83 Mn |
| Jun 30, 2016 | 26.80 Mn |
| Dec 31, 2015 | 26.77 Mn |